AI in Pharmacovigilance Course: Comprehensive Introduction to the Transformative Impact of Artificial Intelligence on Drug Safety and Monitoring (ONLINE EVENT: May 18, 2026) [Yahoo! Financ...
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) (TAK)
Company Research
Source: Yahoo! Finance
signal detection, and advancing risk management in pharmacovigilance, alongside adapting to current regulatory changes. Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance (May 18, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide a comprehensive introduction to the transformative impact of artificial intelligence on drug safety and monitoring. This course covers the fundamentals of AI technology, its applications in pharmacovigilance and practical insights into leveraging AI tools for efficient adverse event reporting, signal detection and risk management. Through a mix of theoretical knowledge and practical examples, participants will gain the understanding of available AI solutions in pharmacovigilance practices as well as current regulatory advances. Who Should Attend: Who should attend? Pharmacovigilance specialists Drug safety officers Regulatory affairs professionals Clinical research associates
Show less
Read more
Impact Snapshot
Event Time:
TAK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TAK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TAK alerts
High impacting Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of) news events
Weekly update
A roundup of the hottest topics
TAK
News
- Takeda Pharmaceutical (TAK) was upgraded by Sanford C. Bernstein from "market perform" to "outperform".MarketBeat
- Takeda (TAK) Receives FDA Priority Review for Rusfertide in PV Treatment [Yahoo! Finance]Yahoo! Finance
- Major biopharmaceutical company to lay off nearly 250 workers in MA [Yahoo! Finance]Yahoo! Finance
- DIA's LIFT Series Brings Startup Pitch Competitions, Innovation Programming to Global Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Massachusetts' largest biopharma employer to lay off 237 in Cambridge [Yahoo! Finance]Yahoo! Finance
TAK
Sec Filings
- 4/6/26 - Form 3
- 4/6/26 - Form 3
- 4/6/26 - Form 3
- TAK's page on the SEC website